Four in Every 10 U.S. Adults Is Now Obese; Severe Obesity Rising
Medically reviewed by Drugs.com.
By Ernie Mundell HealthDay Reporter
TUESDAY, Sept. 24, 2024 -- Over 40 percent of U.S. adults are now obese, with rates roughly the same for men and women, new government data shows.
Obesity rates fluctuated with age and fell as levels of education increased, said the report from the U.S. Centers for Disease Control and Prevention.
The only good news: The rate of adult obesity did not change between 2013 and 2023, said a team led by Samuel Emmerich, an epidemiologist at the CDC's National Center for Health Statistics.
Obesity was defined as a BMI of 30 or above. For example, a person 5-foot 10-inches tall with a weight of 210 pounds has BMI of 30. So does a 5-foot-6 person weighing 185 lbs.
Rates of severe obesity have risen among U.S. adults, however.
In 2013, 7.7% of adults were severely obese, but that number jumped to 9.7% 10 years later.
According to the CDC, severe obesity begins at a BMI of 40, equivalent to a 5-foot-10-inch person weighing 280 lbs.
The peak time for obesity was middle age: 46.4% of adults ages 40 to 59 were obese, compared to 35.5% of those aged 20 to 39 and 38.9% of those over the age of 60, the report found. Similar trends were seen among people with severe obesity.
While 44.6% of adults with only a high school degree were obese, that number fell to 31.6% for those with a college degree.
The bottom line, according to the NCHS team: "In the United States, the prevalence of obesity in adults remains above the Healthy People 2030 goal of 36.0%, but from 2013–2014 through August 2021–August 2023, the age-adjusted prevalence of obesity in adults did not change significantly."
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-09-25 00:00
Read more
- Overall Prevalence of Anemia 9.3 Percent in August 2021 to August 2023
- Combo Treatment With Xalnesiran Shows Promise in Patients With Hep B
- Novavax Initiates Phase 3 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza
- About One-Third Eligible for Weight Loss Drugs Meet Trial Exclusion Criteria
- More Women Are Being Diagnosed With Breast Cancer at Later Stages
- Celiac Disease Linked to Higher Risk for Developing Alopecia Areata
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions